Neuberger Berman Canada’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.34M Buy
6,535
+3,802
+139% +$884K 0.25% 99
2017
Q2
$664K Sell
2,733
-833
-23% -$196K 0.12% 232
2017
Q1
$852K Sell
3,566
-12,465
-78% -$2.9M 0.17% 193
2016
Q4
$3.37M Buy
16,031
+10,572
+194% +$2.19M 0.85% 23
2016
Q3
$1.26M Sell
5,459
-1,060
-16% -$259K 0.38% 59
2016
Q2
$1.51M Buy
6,519
+1,372
+27% +$316K 0.48% 37
2016
Q1
$1.38M Sell
5,147
-841
-14% -$241K 0.51% 53
2015
Q4
$1.87M Buy
5,988
+1,446
+32% +$431K 0.74% 25
2015
Q3
$1.24M Buy
4,542
+14
+0.3% +$4.3K 0.54% 47
2015
Q2
$1.37M Buy
4,528
+1,367
+43% +$408K 0.37% 105
2015
Q1
$941K Buy
3,161
+84
+3% +$23.9K 0.25% 115
2014
Q4
$792K Sell
3,077
-923
-23% -$231K 0.13% 131
2014
Q3
$965K Buy
+4,000
New +$895K 0.15% 129

Other funds holding AGN

Neuberger Berman Canada's AGN Position: Q3 2017 in Review

Neuberger Berman Canada increased its Allergan plc (AGN) stake by 139% in Q3 2017, buying an estimated $884K and bringing the position to 6,535 shares worth $1.34M. The position accounts for 0.25% of the portfolio, ranked #99.

Neuberger Berman Canada first reported a position in AGN in Q3 2014 and has held it in 13 quarters since. The position peaked at $3.37M in Q4 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Neuberger Berman Canada held 6,535 shares of Allergan plc worth $1.34M as of Q3 2017.
  • Neuberger Berman Canada bought 3,802 Allergan plc shares in Q3 2017, an estimated $884K.
  • Allergan plc made up 0.25% of Neuberger Berman Canada's portfolio in Q3 2017, its #99 holding.
  • Neuberger Berman Canada first reported a position in Allergan plc in Q3 2014 and has held it in 13 quarters since.
  • Neuberger Berman Canada's Allergan plc position peaked at $3.37M in Q4 2016.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.